Search
for
Sort by
Research 30 of 1000+
- Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17/TH22 skewing
- An integrated model of alopecia areata biomarkers highlights both TH1 and TH2 upregulation
- An essential role for <i>Rxrα</i> in the development of Th2 responses
- The Role of Serum Th1, Th2, and Th17 Cytokines in Patients with Alopecia Areata: Clinical Implications
- Scalp biomarkers during dupilumab treatment support Th2 pathway pathogenicity in alopecia areata
- Alopecia Universalis Following Two Sequential Traffic Accidents : Possible Association with Increased Th1 and Th17 Cells and Decreased Th2 Cells
- Novel Quinazoline Derivative Induces Differentiation of Keratinocytes and Enhances Skin Barrier Functions against Th2 Cytokine-Mediated Signaling
- Pinkie, the First Viable Germline Hypomorph Allele of Retinoid X Receptor Alpha, Reveals an Important Role for RXRa in Th2 Development.
- The effect of 5-α reductase inhibitor on Th1, Th2, and Th17 cell-related inflammatory response in BPH
- 917 Frontal fibrosing alopecia scalp profiling links Th1/Th2 and JAK3 activation with fibrosis and loss of follicular stem cells
- 1315 An Integrated model of alopecia areata biomarkers highlights both Th1/Th2 upregulation, with stronger correlations between Th2 activation and disease severity
- Th22 is the effector cell of thymosin β15-induced hair regeneration in mice
- Th1/Th2 PB balance and CD200 expression of patients with active severe alopecia areata
- Influence of Gushen Shengfa Pills Combined Wuling Capsules on Th1/Th2 Cytokines in Patients with Alopecia Areata Disease
- 0085 Th1/Th2 balance, IFN-γ–MHC-I axis, and regulatory T cells define therapeutic response endotypes in alopecia areata
- 772 Alopecia areata shares OX40 activation and Th1 and Th2 increases across atopic backgrounds
- A case of bullous pemphigoid in a malignant melanoma patient following an increased Th2/Th1 ratio in peripheral blood cells after nivolumab treatment
- Verification of the Major Metabolic Oxidation Path for the Naphthoyl Group in Chemoattractant Receptor-Homologous Molecule Expressed on Th2 Cells (CRTh2) Antagonist 2-(2-(1-Naphthoyl)-8-fluoro-3,4-dihydro-1<i>H</i>-pyrido[4,3-<i>b</i>]indol-5(2<i>H</i>)-yl)acetic Acid (Setipiprant/ACT-129968)
- Biomarkers of alopecia areata disease activity and response to corticosteroid treatment
- Netherton syndrome subtypes share IL-17/IL-36 signature with distinct IFN-α and allergic responses
- Alarmin Cytokines as Central Regulators of Cutaneous Immunity
- Alopecia Areata in Severe Atopic Dermatitis Treated With Dupilumab
- Hair eruption initiates and commensal skin microbiota aggravate adverse events of anti-EGFR therapy
- Selective Ablation of Ctip2/Bcl11b in Epidermal Keratinocytes Triggers Atopic Dermatitis-Like Skin Inflammatory Responses in Adult Mice
- Experimental evaluation of ebastine, a second-generation anti-histamine, as a supportive medication for alopecia areata
- Alopecia areata and risk of atopic and autoimmune conditions: population-based cohort study
- Decreased CD200R expression on monocyte-derived macrophages correlates with Th17/Treg imbalance and disease activity in rheumatoid arthritis patients
- A novel therapeutic paradigm for patients with extensive alopecia areata
- Regulatory T cells are required for normal and activin‐promoted wound repair in mice
- Extracellular vesicles from IFN-γ-primed mesenchymal stem cells repress atopic dermatitis in mice